Insights

Innovative Research Focus TRIO specializes in translational oncology research, leveraging cutting-edge science and a global network to accelerate drug development, making it an attractive partner for organizations seeking advanced clinical trial solutions in cancer therapies.

Recent Strategic Collaborations Partnership with Kanvasbio and collaborations with leading institutions like MD Anderson Cancer Center highlight TRIO’s active engagement in preclinical and translational research, presenting opportunities for joint ventures and expanded research collaborations.

Recognition and Industry Credibility The company's Nobel Prize award in chemistry for quantum dots underscores its innovative capabilities and industry recognition, bolstering its reputation as a leader in medical imaging and diagnostic technologies.

Growing Market Presence With a revenue range of $25M to $50M and recent high-profile partnerships, TRIO is positioned for growth within the clinical research services sector, offering potential opportunities for service expansion and technology integration.

Tech-Driven Operations Utilizing advanced tools such as SAS, Microsoft Azure, and GDPR compliance, TRIO demonstrates a commitment to data security and operational efficiency, making it an ideal partner for organizations prioritizing innovative and compliant research solutions.

Similar companies to TRIO - Translational Research in Oncology

TRIO - Translational Research in Oncology Tech Stack

TRIO - Translational Research in Oncology uses 8 technology products and services including SAS/GRAPH, SAS, GDPR, and more. Explore TRIO - Translational Research in Oncology's tech stack below.

SAS/GRAPH
Business Intelligence
SAS
Business Intelligence
GDPR
Certificates
Cookie Notice
Cookie Compliance
Salesforce
Customer Relationship Management
MySQL
Database
Microsoft Azure
Platform As A Service
All in One SEO
Search Engines

Media & News

TRIO - Translational Research in Oncology's Email Address Formats

TRIO - Translational Research in Oncology uses at least 1 format(s):

TRIO - Translational Research in Oncology Email Formats	Example	Percentage
First.Last@trioncology.org	John.Doe@trioncology.org	49%
FLast@trioncology.org	JDoe@trioncology.org	1%
First.Middle@trioncology.org	John.Michael@trioncology.org	1%
First.Last@trioncology.org	John.Doe@trioncology.org	49%

Frequently Asked Questions

What is TRIO - Translational Research in Oncology's official website and social media links?

TRIO - Translational Research in Oncology's official website is trioncology.org and has social profiles on LinkedIn.

What is TRIO - Translational Research in Oncology's SIC code NAICS code?

TRIO - Translational Research in Oncology's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 5417 - Scientific Research and Development Services.

How many employees does TRIO - Translational Research in Oncology have currently?

As of January 2026, TRIO - Translational Research in Oncology has approximately 248 employees across 5 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: C. M.Chief Financial Officer: A. A. N.Vice President Human Resources: C. P.. Explore TRIO - Translational Research in Oncology's employee directory with LeadIQ.

What industry does TRIO - Translational Research in Oncology belong to?

TRIO - Translational Research in Oncology operates in the Research Services industry.

What technology does TRIO - Translational Research in Oncology use?

TRIO - Translational Research in Oncology's tech stack includes SAS/GRAPHSASGDPRCookie NoticeSalesforceMySQLMicrosoft AzureAll in One SEO.

What is TRIO - Translational Research in Oncology's email format?

TRIO - Translational Research in Oncology's email format typically follows the pattern of First.Last@trioncology.org. Find more TRIO - Translational Research in Oncology email formats with LeadIQ.

When was TRIO - Translational Research in Oncology founded?

TRIO - Translational Research in Oncology was founded in 1997.

TRIO - Translational Research in Oncology

Research ServicesAlberta, Canada201-500 Employees

TRIO is a unique, full-service oncology clinical research organization (CRO) that leverages the strengths of our worldwide network of Investigators, academic leaders, patient advocates and our clinical research team to accelerate drug development. We’ve spent decades conducting oncology trials from inception to completion, focusing on the best research and science to guide the development of innovative and biologically sound therapies. This translational research model allows us to bring targeted concepts into clinics on the most rational development path. 

We find the shortest course to save lives. We are focused. We care. We deliver.